Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy

Rheumatol Int. 2006 Dec;27(2):201-2. doi: 10.1007/s00296-006-0187-3. Epub 2006 Aug 25.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / drug therapy
  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunophenotyping
  • Lymphocyte Subsets / drug effects
  • Lymphocytosis / chemically induced*
  • Lymphocytosis / classification
  • Middle Aged
  • Neutropenia / chemically induced*
  • T-Lymphocytes / drug effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha
  • Adalimumab